Webpackaging logo

Schreiner MediPharm Supplies Compact, Multi-Lingual Booklet-Label for Clinical Trial at Sanofi

  • Schreiner MediPharm
Health, Pharmaceuticals

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the pharmaceutical industry, has developed a compact Booklet-Label for a needle protection system used in an international phase III clinical trial conducted by pharmaceutical corporation Sanofi. Comprising over 30 pages, the extensive yet compact booklet contains all required product information in more than 20 languages. 

Accuracy, safety, efficiency and speed are essential to the successful performance of clinical trials. Since most studies are conducted internationally, the investigational drugs must be reliably marked and provided with a complete set of information in several languages. For this purpose, Sanofi required a multi-page label making the product information available in many different languages. In addition, the label needed to firmly adhere to the plastic needle protection system without impairing the system’s functionality. 

The Booklet-Label developed by Schreiner MediPharm is tightly wrapped around the needle protection system. The compact booklet encompasses 32 pages with medicinal information in 22 languages. It reliably adheres to the plastic substrate of the needle protection system and, due to its flexible material construction of thin booklet paper plus film layers, can be easily wrapped around the quadrangular device. A starter tab makes it possible to easily open and re-close the label. 

The Booklet-Label is partially affixed to the device so that the pre-filled syringe and its contents are readily visible after opening. The booklet is equipped with a perforation, allowing for its removal before injection—only a small part of the label which, for instance, may contain variable data, subsequently remains on the device. The label material is suitable for custom overprinting using TTR printers, thus efficiently and flexibly supporting the processes during the clinical trial. 

Schreiner MediPharm’s Clinical Trial Supplies (CTS) team is a competence and service partner for clinical trials. The team has comprehensive expertise in the area of Clinical Trial Supplies and provides individual and flexible consulting support to all customers according to their needs. A process center specializing in Booklet-Labels is dedicated to creating reliable solutions that are optimally adapted to the packaging of investigational drugs.

See also

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.

  • Company News
  • English
  • Modified 07 May 2020
  • Hits 384